김성배
#유방암#식도암#두경부암
|
학력
1993 .03 ~ 1996 .08경희대학교 의학 박사
1989 .09 ~ 1992 .02경희대학교 의학 석사
1981 .03 ~ 1987 .02경희대학교 의학 학사
1989 .09 ~ 1992 .02경희대학교 의학 석사
1981 .03 ~ 1987 .02경희대학교 의학 학사
경력
2007 .10 ~ 현재서울아산병원 교수
2002 .10 ~ 2007 .09서울아산병원 부교수
1998 .10 ~ 2002 .09서울아산병원 조교수
1996 .10 ~ 1998 .09서울아산병원 전임강사
1995 .03 ~ 1996 .09서울아산병원 전임강사대우
1993 .05 ~ 1995 .02서울아산병원 전임의
2002 .10 ~ 2007 .09서울아산병원 부교수
1998 .10 ~ 2002 .09서울아산병원 조교수
1996 .10 ~ 1998 .09서울아산병원 전임강사
1995 .03 ~ 1996 .09서울아산병원 전임강사대우
1993 .05 ~ 1995 .02서울아산병원 전임의
논문
Aspirin use and head and neck cancer survival: an observational study of 11,623 person-years follow-up.
No Association of Positive Superficial and/or Deep Margins with Local Recurrence in Invasive Breast Cancer Treated with Breast-Conserving Surgery.
Radiation-induced esophageal strictures treated with fluoroscopic balloon dilation: clinical outcomes and factors influencing recurrence in 62 patients.
A Phase I/IIa Study of DHP107, a Novel Oral Paclitaxel Formulation, in Patients with Advanced Solid Tumors or Gastric Cancer.
A Randomized Feasibility Study of (18)F-Fluoroestradiol PET to Predict Pathologic Response to Neoadjuvant Therapy in Estrogen Receptor-Rich Postmenopausal Breast Cancer.
Adjuvant Capecitabine for Breast Cancer after Preoperative Chemotherapy.
Basaloid Squamous Cell Carcinoma of the Head and Neck: Subclassification into Basal, Ductal, and Mixed Subtypes Based on Comparison of Clinico-pathologic Features and Expression of p53, Cyclin D1, Epidermal Growth Factor Receptor, p16, and Human Papi
Buparlisib and paclitaxel in patients with platinum-pretreated recurrent or metastatic squamous cell carcinoma of the head and neck (BERIL-1): a randomised, double-blind, placebo-controlled phase 2 trial.
Concordance between plasma-based and tissue-based next-generation sequencing in LOTUS.
Defining Radioiodine-Refractory Differentiated Thyroid Cancer: Efficacy and Safety of Lenvatinib by Radioiodine-Refractory Criteria in the SELECT Trial.
Ipatasertib plus paclitaxel versus placebo plus paclitaxel as first-line therapy for metastatic triple-negative breast cancer (LOTUS): a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial.
Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial.
Phase II, multicentre, randomised trial of eribulin plus gemcitabine versus paclitaxel plus gemcitabine as first-line chemotherapy in patients with HER2-negative metastatic breast cancer.
Pretreatment albumin level predicts survival in head and neck squamous cell carcinoma.
Prevalence and clinical significance of cancer cachexia based on time from treatment in advanced-stage head and neck squamous cell carcinoma.
Quality of life on TSU-68: Combination of docetaxel and TSU-68, an oral antiangiogenic agent, in patients with metastatic breast cancer previously treated with anthracycline.
Reply: (18)F-Fluoroestradiol PET to Predict the Response to Neoadjuvant Treatment of Luminal Breast Cancer.
Trastuzumab emtansine versus treatment of physician's choice in patients with previously treated HER2-positive metastatic breast cancer (TH3RESA): final overall survival results from a randomised open-label phase 3 trial.
Value of extranodal extension detected by computed tomography for predicting clinical response after chemoradiotherapy in head and neck squamous cell cancer.
A randomized feasibility study of 18F-fluoroestradiol positron emission tomography to predict pathological response to neoadjuvant systemic therapy in estrogen receptor-rich postmenopausal breast cancer.
No Association of Positive Superficial and/or Deep Margins with Local Recurrence in Invasive Breast Cancer Treated with Breast-Conserving Surgery.
Radiation-induced esophageal strictures treated with fluoroscopic balloon dilation: clinical outcomes and factors influencing recurrence in 62 patients.
A Phase I/IIa Study of DHP107, a Novel Oral Paclitaxel Formulation, in Patients with Advanced Solid Tumors or Gastric Cancer.
A Randomized Feasibility Study of (18)F-Fluoroestradiol PET to Predict Pathologic Response to Neoadjuvant Therapy in Estrogen Receptor-Rich Postmenopausal Breast Cancer.
Adjuvant Capecitabine for Breast Cancer after Preoperative Chemotherapy.
Basaloid Squamous Cell Carcinoma of the Head and Neck: Subclassification into Basal, Ductal, and Mixed Subtypes Based on Comparison of Clinico-pathologic Features and Expression of p53, Cyclin D1, Epidermal Growth Factor Receptor, p16, and Human Papi
Buparlisib and paclitaxel in patients with platinum-pretreated recurrent or metastatic squamous cell carcinoma of the head and neck (BERIL-1): a randomised, double-blind, placebo-controlled phase 2 trial.
Concordance between plasma-based and tissue-based next-generation sequencing in LOTUS.
Defining Radioiodine-Refractory Differentiated Thyroid Cancer: Efficacy and Safety of Lenvatinib by Radioiodine-Refractory Criteria in the SELECT Trial.
Ipatasertib plus paclitaxel versus placebo plus paclitaxel as first-line therapy for metastatic triple-negative breast cancer (LOTUS): a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial.
Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial.
Phase II, multicentre, randomised trial of eribulin plus gemcitabine versus paclitaxel plus gemcitabine as first-line chemotherapy in patients with HER2-negative metastatic breast cancer.
Pretreatment albumin level predicts survival in head and neck squamous cell carcinoma.
Prevalence and clinical significance of cancer cachexia based on time from treatment in advanced-stage head and neck squamous cell carcinoma.
Quality of life on TSU-68: Combination of docetaxel and TSU-68, an oral antiangiogenic agent, in patients with metastatic breast cancer previously treated with anthracycline.
Reply: (18)F-Fluoroestradiol PET to Predict the Response to Neoadjuvant Treatment of Luminal Breast Cancer.
Trastuzumab emtansine versus treatment of physician's choice in patients with previously treated HER2-positive metastatic breast cancer (TH3RESA): final overall survival results from a randomised open-label phase 3 trial.
Value of extranodal extension detected by computed tomography for predicting clinical response after chemoradiotherapy in head and neck squamous cell cancer.
A randomized feasibility study of 18F-fluoroestradiol positron emission tomography to predict pathological response to neoadjuvant systemic therapy in estrogen receptor-rich postmenopausal breast cancer.
저서
유방암 환자를 위한 치료 안내서 5판
보도자료
"전이성 삼중음성 유방암, 티쎈트릭 추가로 생존기간 2배 연장"
http://www.docdocdoc.co.kr/news/articleView.html?idxno=2001151
유방암 환자들이 겪는 또 다른 고통, '뼈전이 합병증'은 무엇?
https://jhealthmedia.joins.com/article/article_view.asp?pno=20328
침샘암 “전이 가능성 높아 수술 후 관리 중요”
http://www.100ssd.co.kr/news/articleView.html?idxno=65158
http://www.docdocdoc.co.kr/news/articleView.html?idxno=2001151
유방암 환자들이 겪는 또 다른 고통, '뼈전이 합병증'은 무엇?
https://jhealthmedia.joins.com/article/article_view.asp?pno=20328
침샘암 “전이 가능성 높아 수술 후 관리 중요”
http://www.100ssd.co.kr/news/articleView.html?idxno=65158
포스팅
Prognostic stratification of pathologic stage in patients with preoperative chemoradiotherapy followed by curative esophagectomy for localized esophageal squamous cell carcinoma
FcrR3A-158 polymorphism and stromal tumor-infiltrating lymphocytes as predictive markers for trastuzumab-based treatment in patients with metastatic HER2-positive breast cancer
Risk factors of morbidity and mortality after definitive radiation or chemoradiotherapy in elderly patients with head and neck squamous cell carcinoma
Predictive role of stromal tumor infiltrating lymphocytes (TILs) in patients with metastatic HER2-positive breast cancer (BC) treated with trastuzumab
Expression patterns of HER-2, EGFR, c-Met, c-Kit, and p53 in head and neck adenoid cystic carcinoma with high-grade transformation
Ki 67 Expression and Oncotype DXTM Recurrence Score in Korean Breast Cancer Patients
Clinical features and outcomes of leptomeningeal metastasis in patients with breast cancer: a single center experience
Can concurrent chemoradiotherapy replace surgery and postoperative radiation in locally advanced stage III/IV tonsillar carcinoma?
FcrR3A-158 polymorphism and stromal tumor-infiltrating lymphocytes as predictive markers for trastuzumab-based treatment in patients with metastatic HER2-positive breast cancer
Risk factors of morbidity and mortality after definitive radiation or chemoradiotherapy in elderly patients with head and neck squamous cell carcinoma
Predictive role of stromal tumor infiltrating lymphocytes (TILs) in patients with metastatic HER2-positive breast cancer (BC) treated with trastuzumab
Expression patterns of HER-2, EGFR, c-Met, c-Kit, and p53 in head and neck adenoid cystic carcinoma with high-grade transformation
Ki 67 Expression and Oncotype DXTM Recurrence Score in Korean Breast Cancer Patients
Clinical features and outcomes of leptomeningeal metastasis in patients with breast cancer: a single center experience
Can concurrent chemoradiotherapy replace surgery and postoperative radiation in locally advanced stage III/IV tonsillar carcinoma?
영상자료
영상자료 내용이 없습니다.
발표자료
유방암 초진단 환자에서의 혈청 HER2/neu 농도와 진단적 인자들과의 상관성
2-[18F] Fluoro-2-Deoxy-D-Glucose Positron Emission Tomography as Guidance for Primary Treatment in Patients with Advanced-Stage Resectable Squamous Cell Carcinoma of the Larynx and Hypopharynx
18F-FDG PET scan as a predictor of survival of the patients receiving neoadjuvant chemoradiotherapy followed by esophagectomy
Hepatitis B Reactivation During Adjuvant Anthracycline Based Chemotherapy in Patients with Breast Cancer : Single Institution Experience
Comparison between surgical and non-surgical treatment for tonsillar squamous cell carcinoma
18F-FDG PET Scan as a Predictor of Survival of the Patients Receiving Neoadjuvant Chemoradiotherapy Followed by Esophagectomy
Efficacy of gemcitabine alone and in combination with vinorelbine or capecitabine in metastatic breast cancer settings of disease progression after anthracycline and taxane therapy
Multivariate Prognostic Factor Analysis in Patients with Esophageal Cancer Treated with Preoperative Chemoradiotherapy (CRT): The Importance of Pathologic Response and Lymph Node Metastasis
Gemcitabine single or combination chemotherapy in post anthracycline and taxane salvage treatment of metastatic breast cancer: Retrospective analysis of 124 patients
Hepatitis B Reactivation During Adjuvant Anthracycline Based Chemotherapy in Patients with Breast Cancer : Single Institution Experience
절제 불가능한 식도암에서의 근치적 동시 항암화학 방사선치료의 성적과 재발 양상
Incidence of chemotherapy-related amenorrhea and menopause-specific quality of life after adjuvant therapy in premenopausal breast cancer patients: A prospective study
Cytokeratin Expression Profiling in the Matrix-Producing Metaplastic Carcinoma of Breast
BRCA1/2 Associated Korean Breast Cancer has more often ER/C-ERBB2 negative phenotype
Bone mineral density and the risk of breast cancer
Clinicopathologic Significance of a-Basic Crystallin in Breast Cancer
Prognostic Significance of Stem Cell Property in Breast Carcinoma: Iuumonhistochemical Study for CD44s and CD24
Predictor of locoregional recurrence to plan breast conservation therapy for breast cancer
Prognostic Significance of Stem cell Property in Breast Carcinoma: Immunohistochemical Study for CD44s and CD24
Intensity-modulated Radiotherapy for Nasopharyngeal Carcinoma in Asan Medical Center Experience
Results of Definitive Chemoradiation Therapy for Unresectable Esophageal Cancer
Anagesic score in patient with bone metastastasis during administration of zoledronic acid administration
Multivariate prognostic factor analysis in patients with esophageal cancer treated with preoperative chemoradiation: the importance of pathologic response and lymph node metastasis
2-[18F] Fluoro-2-Deoxy-D-Glucose Positron Emission Tomography as Guidance for Primary Treatment in Patients with Advanced-Stage Resectable Squamous Cell Carcinoma of the Larynx and Hypopharynx
18F-FDG PET scan as a predictor of survival of the patients receiving neoadjuvant chemoradiotherapy followed by esophagectomy
Hepatitis B Reactivation During Adjuvant Anthracycline Based Chemotherapy in Patients with Breast Cancer : Single Institution Experience
Comparison between surgical and non-surgical treatment for tonsillar squamous cell carcinoma
18F-FDG PET Scan as a Predictor of Survival of the Patients Receiving Neoadjuvant Chemoradiotherapy Followed by Esophagectomy
Efficacy of gemcitabine alone and in combination with vinorelbine or capecitabine in metastatic breast cancer settings of disease progression after anthracycline and taxane therapy
Multivariate Prognostic Factor Analysis in Patients with Esophageal Cancer Treated with Preoperative Chemoradiotherapy (CRT): The Importance of Pathologic Response and Lymph Node Metastasis
Gemcitabine single or combination chemotherapy in post anthracycline and taxane salvage treatment of metastatic breast cancer: Retrospective analysis of 124 patients
Hepatitis B Reactivation During Adjuvant Anthracycline Based Chemotherapy in Patients with Breast Cancer : Single Institution Experience
절제 불가능한 식도암에서의 근치적 동시 항암화학 방사선치료의 성적과 재발 양상
Incidence of chemotherapy-related amenorrhea and menopause-specific quality of life after adjuvant therapy in premenopausal breast cancer patients: A prospective study
Cytokeratin Expression Profiling in the Matrix-Producing Metaplastic Carcinoma of Breast
BRCA1/2 Associated Korean Breast Cancer has more often ER/C-ERBB2 negative phenotype
Bone mineral density and the risk of breast cancer
Clinicopathologic Significance of a-Basic Crystallin in Breast Cancer
Prognostic Significance of Stem Cell Property in Breast Carcinoma: Iuumonhistochemical Study for CD44s and CD24
Predictor of locoregional recurrence to plan breast conservation therapy for breast cancer
Prognostic Significance of Stem cell Property in Breast Carcinoma: Immunohistochemical Study for CD44s and CD24
Intensity-modulated Radiotherapy for Nasopharyngeal Carcinoma in Asan Medical Center Experience
Results of Definitive Chemoradiation Therapy for Unresectable Esophageal Cancer
Anagesic score in patient with bone metastastasis during administration of zoledronic acid administration
Multivariate prognostic factor analysis in patients with esophageal cancer treated with preoperative chemoradiation: the importance of pathologic response and lymph node metastasis